human migration Breaking News Genomic Data Analytics Firm Galatea Bio Raises $25M Epicrispr Biotechnologies Raises $68M in Series B Financing, Prepares to Launch Clinical Trial Mainz Biomed Launches Study for Colon Cancer Screening Test, Aiming for Added Sensitivity Invivoscribe Acute Myeloid Leukemia Assay Nabs Regulatory Compliance in UK, Switzerland ICER Finds Nanoscope Retinal Gene Therapy Cost Effective in $67,400 to $101,300 Price Range NCI Awards up to $150M Under Genomic Characterization Center Contract
